Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard
Business Of Biotech
00:00
How to Navigate the Patient Recruitment Process in Clinical Trials
The first trial in GVHD is indeed something where you need a very, very obvious CRO and everything. We are going on site every time there's a patient, they have questions. They never manipulate it such as a product. And here, especially in the ematology oncology field, now the potential of improving the outcome for the patient is well-recognized by the doctors. So here, because it's an adjuvant, not directly treating the disease, I think it will be more easy to refer to a patient.
Transcript
Play full episode
